Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of Etoricoxib 120 mg tablets vs Arcoxia 120 mg tablets in healthy Thai volunteers under fasting conditions
TCTR20210924005Phase 1Not yet recruiting
- Sponsor
- Bio-innova
- Start
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of etoricoxib in pain and Inflammatory Disorders (2 arms), sponsored by Bio-innova. Planned start Dec 2021; status: not yet recruiting.
02
Drugs
etoricoxib
03
Conditions
painInflammatory Disorders
Beyond the preview
Go deeper on TCTR20210924005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210924005.